Meet the visionaries and scientists driving the future of longevity research and cancer therapeutics at 199 Bio.
Leadership
Boris Djordjevic
Founder & CEO
Founder of the 199 group of companies, developing breakthrough therapies in cellular reprogramming and epigenetic treatments for aging and cancer.
Antonia Schultze-Mosgau
Chief Operating Officer
Serial entrepreneur and longevity expert, translating cutting-edge research into scalable health applications. Oxford All-Innovate Award winner.
Dr. Avi Roy
Chief Scientific Officer
Oxford biomedical scientist pioneering cellular rejuvenation. President of Biogerontology Research Foundation and discoverer of 12 novel geroprotective drugs.
Dr. Qinghua Lyu
Chief Technical Officer
Drug development expert from National University of Singapore leading chemical sciences division. The chemistry genius behind our breakthrough senolytic compounds.
ZY
Zico Yip
Chief Operating Officer
General Manager of our laboratories and manufacturing facilities, bringing deep biotech experience with successful fundraising, exits, and investments.
Join Our Team
We're always looking for exceptional talent to join our mission of revolutionizing cancer treatment and extending healthy human lifespan.
